Jennifer Foster
0000-0002-2126-9768
7 papers found
Refreshing results…
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019
Treatment of High-Risk Neuroblastoma
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor
Activity of Crizotinib in Patients with ALK-aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Severe COVID‐19 infection in a child receiving immunotherapy for cancer
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma
Blood product administration during high risk neuroblastoma therapy
Missing publications? Search for publications with a matching author name.